Suchergebnisse - "Gharibkandi, Nasrin Abbasi"

PubPharm (12)

1

Au109Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers : studies on the applicability of 109Pd/109mAg in vivo generator in combined β- auger electron therapy

enthalten in: EJNMMI radiopharmacy and chemistry | 2023

von Gharibkandi, N. | Wawrowicz, K. | Majkowska-Pilip, A. | +3

2

Au109Pd core–shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined $ β^{−} $ auger electron therapy

enthalten in: EJNMMI radiopharmacy and chemistry | 2023

von Gharibkandi, N. | Wawrowicz, K. | Majkowska-Pilip, A. | +3

3

198Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular Carcinoma

enthalten in: International journal of molecular sciences | 2023

von Gharibkandi, N. | Żuk, M. | Muftuler, F. | +3

4

Nanostructures as Radionuclide Carriers in Auger Electron Therapy

enthalten in: Materials (Basel, Switzerland) | 2022

von Gharibkandi, N. | Gierałtowska, J. | Wawrowicz, K. | +1

5

The Influence of Kidneys Ion Transport Inhibitors on the Pharmacokinetic and Tumor Uptake Behaviors of a HER2-targeted Small Size Radiolabeled Peptide

enthalten in: Current drug metabolism | 2022

von Gharibkandi, N. | Molavipordanjani, S. | Mardanshahi, A. | +1

6

The Influence of Kidneys Ion Transport Inhibitors on the Pharmacokinetic and Tumor Uptake Behaviors of a HER2-targeted Small Size Radiolabeled Peptide

enthalten in: Current drug metabolism | 2022

von Gharibkandi, N. | Molavipordanjani, S. | Mardanshahi, A. | +1

7

The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines

enthalten in: Molecular biology reports | 2021

von Mardanshahi, A. | Gharibkandi, N. | Vaseghi, S. | +2

8

The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines

enthalten in: Molecular biology reports | 2021

von Mardanshahi, A. | Gharibkandi, N. | Vaseghi, S. | +2

9

The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines

enthalten in: Molecular biology reports | 2021

von Mardanshahi, A. | Gharibkandi, N. | Vaseghi, S. | +2

10

The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines

enthalten in: Molecular biology reports | 2021

von Mardanshahi, A. | Gharibkandi, N. | Vaseghi, S. | +2